Streptococcal inhibitor of complement promotes innate immune resistance phenotypes of invasive M1T1 group A Streptococcus. by Pence, Morgan A et al.
Cogen, AL; Yamasaki, K; Muto, J; Sanchez, KM; Crotty Alexander,
L; Tanios, J; Lai, Y; Kim, JE; Nizet, V; Gallo, RL (2010) Staphylococ-
cus epidermidis antimicrobial delta-toxin (phenol-soluble modulin-
gamma) cooperates with host antimicrobial peptides to kill group
A Streptococcus. PLoS One, 5 (1). e8557. ISSN 1932-6203
Downloaded from: http://researchonline.lshtm.ac.uk/1621266/
Usage Guidelines
Please refer to usage guidelines at http://researchonline.lshtm.ac.uk/policies.html or alterna-
tively contact researchonline@lshtm.ac.uk.
Available under license: Creative Commons Attribution http://creativecommons.org/licenses/by/2.5/
Staphylococcus epidermidis Antimicrobial d-Toxin
(Phenol-Soluble Modulin-c) Cooperates with Host
Antimicrobial Peptides to Kill Group A Streptococcus
Anna L. Cogen1,2, Kenshi Yamasaki1, Jun Muto1, Katheryn M. Sanchez3, Laura Crotty Alexander4,
Jackelyn Tanios1, Yuping Lai1, Judy E. Kim3, Victor Nizet4,5, Richard L. Gallo1,4*
1Division of Dermatology, University of California San Diego, San Diego, California, United States of America, 2Department of Bioengineering, University of California San
Diego, San Diego, California, United States of America, 3Department of Chemistry and Biochemistry, University of California San Diego, San Diego, California, United
States of America, 4Department of Pediatrics, School of Medicine, University of California San Diego, San Diego, California, United States of America, 5 Skaggs School of
Pharmacy and Pharmaceutical Sciences, University of California San Diego, San Diego, California, United States of America
Abstract
Antimicrobial peptides play an important role in host defense against pathogens. Recently, phenol-soluble modulins (PSMs)
from Staphylococcus epidermidis (S. epidermidis) were shown to interact with lipid membranes, form complexes, and exert
antimicrobial activity. Based on the abundance and innocuity of the cutaneous resident S. epidermidis, we hypothesized that
their PSMs contribute to host defense. Here we show that S. epidermidis d-toxin (PSMc) is normally present in the epidermis
and sparsely in the dermis of human skin using immunohistochemistry. Synthetic d-toxin interacted with neutrophil
extracellular traps (NETs) and colocalized with cathelicidin while also inducing NET formation in human neutrophils. In
antimicrobial assays against Group A Streptococcus (GAS), d-toxin cooperated with CRAMP, hBD2, and hBD3. In whole blood,
addition of d-toxin exerted a bacteriostatic effect on GAS, and in NETs, d-toxin increased their killing capacity against this
pathogen. Coimmunoprecipitation and tryptophan spectroscopy demonstrated direct binding of d-toxin to host
antimicrobial peptides LL-37, CRAMP, hBD2, and hBD3. Finally, in a mouse wound model, GAS survival was reduced
(along with Mip-2 cytokine levels) when the wounds were pretreated with d-toxin. Thus, these data suggest that S.
epidermidis–derived d-toxin cooperates with the host-derived antimicrobial peptides in the innate immune system to
reduce survival of an important human bacterial pathogen.
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Introduction
Antimicrobial peptides (AMPs) are critically important in the
host’s defense against infections. In particular, cathelicidins are an
important class of mammalian AMPs as cathelicidin-deficient mice
have enhanced susceptibility to skin and other infections,
providing evidence that AMPs are critical to the innate immune
defense[1,2,3,4]. AMPs have been shown to be important in
multiple cell types, including, but not limited to, macrophages,
neutrophils, mast cells, and epithelial cells such as skin keratino-
cytes. Pathogens come into contact with AMPs via host secretory
mechanisms and phagocytosis. In addition, it has recently been
suggested that microbes can also be killed by binding to insoluble
released nucleic acids, histones and associated with AMPs. This
structure can be produced by mast cells or neutrophils, where it is
known as neutrophil extracellular traps (NETS) [5,6]. It has been
suggested that NETs entwine and kill circulating pathogens in a
web of DNA, histones, and AMPs.
Cathelicidins have multiple functionalities. The peptides provide
protection through immuno-modulation, inducing chemotaxis, and
through direct pore-formation of a broad range of infectious agents
including fungi, viruses, and bacteria. LL-37, a active peptide form
of human cathelicidin, is suggested to form an amphipathic a-helix
that subsequently inserts into negatively charged membranes
forming veritable holes [7]. Previous reports suggest that cellular
perforation requires multiple LL-37 peptides which coalesce to form
oligomeric complexes [8]. Although complexes have been shown to
form, it is not known as to whether LL-37 physically forms
heterologous complexes with other antimicrobial a-helical peptides.
Staphylococcus epidermidis (S. epidermidis), the most prevalent of
many cutaneous resident microflora, is generally innocuous.
Several studies have identified S. epidermidis as a common colonizer
of healthy human skin [9,10] and mouse skin [11]. Much like the
gut, the microbiota of the skin is hypothesized to play a mutually
beneficial role in the cutaneous niche. We have previously
demonstrated that peptides produced by S. epidermidis exhibit
antimicrobial properties, potentially acting as an additional
antimicrobial shield. The physico-chemical properties of the S.
epidermidis PSM, d-toxin, is comparable to those properties of the
Staphylococcus aureus d-toxin. The peptides are similarly a-helical
and form complexes, yet the S. aureus d-toxin, unlike the S.
epidermidis d-toxin, lacks antimicrobial activity [12,13,14]. The
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difference antimicrobial activity may be due to the conditions
under which activity was assayed or the differences in d-toxin
primary sequence (glutamine at position 3 or the addition of a
threonine at position 24 in the S. aureus d-toxin).
Several phenol soluble modulins (PSMs) produced by S. epidermidis,
S. aureus d-toxin derivatives, and Staphylococcus haemolyticus gonococcal
growth inhibitor exhibit antimicrobial properties and activity. The S.
epidermidis PSMs have also been shown to enhance the antimicrobial
activity of LL-37 on Group A Streptococcus (GAS)[15].
Previous studies have similarly reported that host AMPs act in
synergy to kill bacteria [16]. Specifically, LL-37 and hBD2 have been
shown to synergistically kill Group B Streptococcus in vitro [17].
Moreover, host AMPs have been shown to act synergistically with an
antimicrobial peptide produced by L. lactis to inhibitE. coli [18]. Thus,
we sought to determine whether the antimicrobial d-toxin, also
known as PSMc, produced by the resident cutaneous microbe, S.
epidermidis, could interact with the host antimicrobials leading to
greater pathogen inhibition and enhancement of the host’s innate
immune system.
Here, we demonstrate that the antimicrobial PSMs contribute to
host innate immunity through interacting with and amplifying the
cutaneous antimicrobial response. These data illustrate a novel means
by which d-toxin contributes to the innate immune system, pointing
towards a beneficial role for S. epidermidis on the skin’s surface.
Results
d-Toxin Is Deposited on the Skin and Binds to Neutrophil
Extracellular Traps
Phenol soluble modulins are multifunctional and can act to
enhance virulence when invasive [19], or as antimicrobials when
in direct contact with pathogens such as GAS. To further evaluate
the relevance of PSMs as surface antimicrobials on human skin we
first determined if d-toxin was detectable on normal human skin.
Immunohistochemistry demonstrated that d-toxin is abundantly
detectable in the normal epidermis, hair follicle and sparsely in the
dermis (Figure 1a). Similar staining was observed in a second skin
sample from a different individual and staining was confirmed
with a second custom-made anti-d-toxin antibody (data not
shown). It is unclear if the two different antibodies recognize
different epitopes, as the commercially available epitope is not
known. Next, since injured skin rapidly accumulates neutrophils at
sites of infection and injury, and these cells act in part to protect
the skin through the formation of neutrophil extracellular traps
(NETs) containing antimicrobial peptides [6,20], we evaluated if d-
toxin from surface S. epidermidis could interact with NETs and
contribute to their activity. d-toxin was added to PMA-induced
neutrophil extracellular traps (NETs) in culture. Addition of d-
toxin to these cells showed that d-toxin bound to the NETs and
colocalized with cathelicidin endogenously released from the
neutrophil (Figure 1b). The specifity of the antibody for d-toxin is
demonstrated by lack of staining of normal human keratinocytes in
the absence of d-toxin but positive staining in the presence of d-
toxin (Figure 1c). As the high isoelectric point of this peptide
predicts that this association with NETs could occur through DNA
binding, d-toxin association with DNA was next directly evaluated
using tryptophan spectroscopy. In buffer alone, d-toxin’s trypto-
phan emits maximally at 341 nm. In the presence of neutrophil
DNA, the maximal emission shifted to 331 nm (Figure 1d). The
blue shift caused by the presence of neutrophil DNA suggested a
direct association with d-toxin. Finally, in addition to interacting
with NETs, we sought to determine if d-toxin could also induce
Figure 1. d-toxin is deposited in the skin by S. epidermidis andbinds neutrophil extracellular traps. a, normal healthy human skin stained for
d-toxin, showed deposition in the epidermis and dermis. Inset is 406magnification of d-toxin in dermis. Bar represents 50 mm. This is a single specimen
representative of two. Nuclei are labeled with DAPI (blue) and d-toxin is labeled with Alexa fluor 488 (green). The far left panel depicts the IgG control for
the anti d-toxin staining. b, d-toxin was added to neutrophil extracellular traps (NETs), which were subsequently stained for LL-37 and d-toxin. Staining
shows colocalization of antimicrobial peptides along DNA strands. Bar represents 20 mm. Nuclei are labeled with DAPI (blue), d-toxin is labeled with
Alexa fluor 488 (green), and LL-37 is labeled with Alexa fluor 568 (red). The far left panel depicts the IgG control for the anti d-toxin and anti LL-37
staining. c, primary keratinocytes incubated with (+ d-toxin) and without (-d-toxin) d-toxin then anti d-toxin staining evaluated. Nuclei are stained with
DAPI (blue) and d-toxin is labeled with Alexa fluor 568 (red). d, tryptophan spectroscopy of d-toxin in the presence and absence of neutrophil DNA.
doi:10.1371/journal.pone.0008557.g001
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formation of NETs in vitro. Here, freshly isolated human
neutrophils were stimulated with d-toxin, or PMA as a positive
control. Like PMA, d-toxin was able to induce NETs formation
(Figure 2). Thus, these data demonstrate that d-toxin derived from
S. epidermidis is deposited on the skin and induces formation of and
interacts with NETs.
d-Toxin Enhances Endogenous Antimicrobial Activity
To determine whether d-toxin was able to cooperatively
enhance bacterial killing of host AMPs, GAS survival was assessed
in the presence of d-toxin and CRAMP, hBD2, and hBD3. The
presence of d-toxin and low concentrations of host AMPs
increased GAS killing in a cooperative manner (Figure 1b and
1c; Figure 3a).
Since d-toxin enhanced the activity of AMPs, we investigated
whether d-toxin could enhance antimicrobial activity of whole
blood. For this, d-toxin was added to whole blood containing GAS
at concentrations below the calculated in vitro MIC against this
pathogen. Over time, GAS was able to grow in blood without
d-toxin, bacteriostasis was achieved in blood containing 2–4 mM
d-toxin (Figure 3d), As d-toxin’s ability to increase bacterial killing
by whole blood may in part be due to the contribution of
neutrophil extracellar traps (NETs), and d-toxin and closely
related peptides have been known to lyse red blood cells and
neutrophils [19], we next examined if the activity of d-toxin in the
presence of neutrophils is aided by DNA forming the NET.
Treatment of NETs and d-toxin with DNAse eliminated the
capacity of both the NETs alone, or NETs with d-toxin, to inhibit
GAS survival (Figure 3e). Hence, the addition of d-toxin to whole
blood or to NETs increases their killing capacity.
d-Toxin Physically Binds to Host-Derived AMPs
Since previous studies suggest that AMPs form heterodimeric
and homodimeric complexes [21], and because we found that
d-toxin colocalizes with LL-37 in NETs, we hypothesized that
d-toxin physically binds to the host derived AMPs. In order to
determine whether d-toxin could associate with LL-37 and
CRAMP, synthetic host AMPs were added to S. epidermidis cell-
free, stationary phase supernatant, naturally containing d-toxin.
Precipitation of d-toxin followed by an immunoblot for LL-37 and
CRAMP demonstrated that d-toxin physically bound to the host
derived peptides (Figure 4a).
In order to further confirm interaction between d-toxin and the
host AMPs, tryptophan spectroscopy was performed on d-toxin in
the presence and absence of host AMPs. Unlike d-toxin, that has a
tryptophan at position 15, LL-37, CRAMP, hBD2, and hBD3 are
spectroscopically silent because they lack a tryptophan. Due to the
spectroscopic silence of the host AMPs, a maximal tryptophan
emission shift in d-toxin during incubation with a host AMP would
signify an interaction with and structural change of d-toxin. To
determine the ability of the host AMPs to interact with d-toxin, the
peptide was incubated with host AMPs and tryptophan emission
was monitored upon excitation at 290 nm (Figure 4b and 4c). We
found that d-toxin maximal tryptophan emission shifted from
341 nm to 344 nm in the presence of LL-37 and CRAMP,
indicating a greater exposure of the tryptophan to the aqueous
environment. Conversely, in the presence of hBD2 and hBD3,
d-toxin’s maximal tryptophan emission shifted from 341 nm to
339 nm, indicating that the tryptophan resides in a more
hydrophobic and embedded environment (Figure 4b and 4c). In
addition, we observed that the emission spectra intensity increased
Figure 3. d-toxin cooperates with host antimicrobial peptides and enhances whole blood and NET killing of GAS. d-toxin cooperates
with host antimicrobial peptides CRAMP (a), hBD2 (b), and hBD3 (c) to kill GAS. d, in whole blood, increasing concentrations of synthetic d-toxin
rendered GAS bacteriostatic. e, d-toxin added to NETs showed greater GAS killing than NET killing alone. The effect was abrogated by DNase. Data are
representative of 2 individual experiments performed in triplicate. *p,0.05. Student’s t-test.
doi:10.1371/journal.pone.0008557.g003
Figure 2. d-toxin induces NET formation. Freshly isolated human
neutrophils were cultured with media only (unstimulated), 25 nM PMA,
or 6 mM d-toxin for 4 hours. Like PMA, d-toxin induced NET formation as
seen by the DNA strands (white arrows).
doi:10.1371/journal.pone.0008557.g002
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upon incubation with LL-37 and CRAMP and decreased upon
incubation with hBD2 and hBD3 (Figure 4b). Similarly, we
observed that d-toxin undergoes a conformation change in the
presence of genomic keratinocyte DNA. Overall, these data
illustrate that d-toxin directly interacts with, and binds to, host
AMPs.
d-Toxin Reduces GAS Survival and Inflammation in
Mouse Wounds
As we have shown that PSMs may contribute to whole blood
and neutrophil killing of GAS, we sought to determine if PSMs
present in a wound could have a similar protective effect against
bacteria, we utilized a mouse wound model. d-toxin or PBS
control was added to 4 mm full-thickness fresh mouse wounds.
After only 30 minutes, GAS was added to the wounds to mimic an
infected wound. After 18 hours, the infected wounds and
surrounding fascia were harvested. GAS survival was significantly
decreased in mouse wounds pretreated with d-toxin but not PBS
(Figure 5a). Paralleling the GAS infection, Mip-2 (CXCL2) was
significantly decreased in mouse wounds treated with d-toxin
(Figure 5b). These data suggest that d-toxin reduces GAS survival
in vivo and may contribute to the innate immune system.
Discussion
We have previously demonstrated that the PSMd and PSMc
(d-toxin) from S. epidermidis exhibit antimicrobial activity over
pathogens. This activity appeared to result from membrane
disruption, a trait common among many antimicrobials [21].
These data support studies suggesting a role of S. aureus PSMs in
virulence, as the peptides induce pore formation in cells such as
neutrophils [19]. Although the PSMs produced by Staphylococcal sp.
Figure 4. d-toxin physically binds to host derived antimicrobial peptides. Synthetic 1 mM LL-37 or 1 mM CRAMP was added to S. epidermidis
supernatants. a, d-toxin was precipitated and immunoblotted for LL-37 or CRAMP. Immunoblots show co-precipitation of LL-37 or CRAMP with d-
toxin indicating binding. The left and right panels were stained for LL-37 or CRAMP, respectively. The LL-37 or CRAMP positive control standards are
shown in the left lane of each panel. The middle and right lanes show relative quantities of LL-37 or CRAMP that precipitated with d-toxin using anti
d-toxin (right lane) or IgG control to anti d-toxin (middle lane) b, emission spectra of d-toxin’s tryptophan in buffer or in the presence of LL-37,
CRAMP, hBD2, or hBD3. c, table of maximal wavelength emission and shift in wavelength upon addition of host antimicrobial peptide. Data are
representative of 2 individual experiments.
doi:10.1371/journal.pone.0008557.g004
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are clearly pore-forming, the impact on the host is likely in part
contingent upon the nature of the bacterium and area of residence
in the host.
The antimicrobial effect of PSMs on skin pathogens and
enhancement of host derived AMPs suggests a role for S. epidermidis
in the innate immune system of the skin [15]. Other staphylococ-
cal species produce additional or different PSMs that may have
other functions or differ in their activity [19]. AMPs have been
previously shown to be crucial components of the innate immune
system, as illustrated by the susceptibility of Camp2/2 mice to GAS
[2]. In addition, bacteria have been shown to benefit the human
host, as suggested by the hygiene hypothesis and other studies on
the gut microflora. Here, we suggest that S. epidermidis benefits the
host and provides an additional layer of protection against skin
pathogens. S. epidermidis rather than acting alone, is able to kill
pathogens by complementing the host’s innate immune system.
This close interaction of d-toxin with the host AMPs insinuates the
presence of a mutual relationship between host and bacteria.
We have shown that d-toxin is deposited in the epidermis and
sparsely in the dermis in normal healthy human skin. During
scenarios such as injury, d-toxin may then be able to interact with
a variety of cell types including neutrophils. Neutrophils expressing
AMPs and forming NETs facilitate eradication of potentially
dangerous bacteria [6]. In fact, it has also been shown that injury
itself increases AMP production and it is not yet known if injury
also induces NETs in circulating neutrophils. As S. epidermidis lives
on the skin, injury would bring the bacterium and products in
close proximity to the innate immune cells. In this occasion,
d-toxin may increase antimicrobial NET activity and likelihood of
pathogen eradication. The NETs illustrate that the host AMPs and
d-toxin intertwine with host DNA. The DNA binding that occurs
by AMPs to the NETs may be more than an artifact of charge
attraction, but rather suggests a novel role for AMPs. Many studies
demonstrate that AMPs cause transcriptional and translational
changes in cells. Of course, AMPs may bind receptors, or affect
signaling pathways, but these peptides, including PSMs, may
directly affect host transcription at the level of DNA binding. Such
DNA binding capacity of d-toxin also suggests a potential role for
S. epidermidis PSMs in bacterial gene regulation, although S. aureus
PSMs are not implicated in such [22].
Phenomena of heterologous complex formation and synergy of
AMPs from different species have been explored only minimally.
Yet AMP synergy has been well documented between AMPs from
the same species [16,17]. Though, one study demonstrated that
bacteriocin synergistically enhanced pleurocidin activity against
E. coli [18]. Although these synergy studies suggest an important
relationship between different peptides, a physical interaction
between the peptides has not yet been proven. Here, we have
shown for the first time, that AMPs from the resident S. epidermidis
interacts physically with the host AMPs. Co-immunoprecipitation
of d-toxin and CRAMP (or LL-37), along with the tryptophan
spectroscopy demonstrated a direct AMP binding. Interestingly,
the precipitated CRAMP peptide, ran slightly higher than the
synthetic peptide positive control. This may have occurred due to
the binding of d-toxin to CRAMP causing a slower migration.
To show that S. epidermidis d-toxin may contribute to the
antimicrobial response in vivo, in a scenario in which the peptide
enters a wound, we added synthetic d-toxin to mimic a wound in
human skin. Significantly less GAS survived in the mouse wounds
that were pretreated with d-toxin as compared to the vehicle (PBS)
control. We also evaluated the levels of a proinflammatory cytokine
Mip-2, as a monitor of infection severity. Mip-2, like the number of
GAS recovered, indicated an increase in bacterial clearance and
general reduction of an inflammatory infection. d-toxin has been
shown to actually induce rather than suppress proinflammatory
signaling [23,24], thus indicating that the reduction in Mip-2 purely
parallels the GAS burden. These data suggest that d-toxin decreases
GAS survival in a wound environment. The mechanism responsible
for decreased survival of GAS is not clear, but may include
neutrophil killing, cooperation with the host AMPs, a surfactant-
based effect or activation of the host’s innate immune response.
Overall, we show here that d-toxin is able to bind to host AMPs.
Moreover, d-toxin enhances blood and NET killing of GAS.
Finally, the functional reduction of GAS survival in a mouse
wound pretreated with d-toxin suggests a beneficial innate
immune role and mutual role for S. epidermidis, a common
constituent of the skin microbiome.
Materials and Methods
Peptides
Formylated d-toxin was commercially synthesized and purified
by HPLC (Quality Controlled Biochemicals, Hopkinton, MA).
Mouse cathelicidin-related antimicrobial peptide (CRAMP) and
LL-37 were commercially synthesized and purified by HPLC
as previously described [25]. Human b-defensins hBD2 and
hBD3 were commercially synthesized and HPLC purified (Peptide
International).
Figure 5. d-toxin reduces GAS survival and inflammation in
mouse wounds. d-toxin or PBS was added to mouse wounds. After
30 minutes, the treated wounds were challenged with GAS. Wounds
were excised, homogenized and plated for GAS CFU/ml (a) or Mip-2
protein levels by ELISA (b). Data are representative of 3 individual
experiments performed with n = 3–4. *p,0.05, Student’s t-test.
doi:10.1371/journal.pone.0008557.g005
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In Vitro Antibacterial Studies
Group A Streptococcus (GAS) was grown to mid-log phase in
Todd-Hewitt Broth (THB, Sigma). A final concentration of
105 CFU/ml were incubated with synthetic d-toxin at 0, 1, 2, 4,
8, and 16 mM in the presence and absence of LL-37 (0, 4, and
8 mM), CRAMP (0, 2, and 4 mM), hBD2 (0, 2, and 4 mM), and
hBD3 (0, 2, and 4 mM). GAS was incubated with peptides in 25%
THB and 75% 1x dulbecco phosphate buffered saline (dPBS) for
4 hours at 37uC and then plated on Todd-Hewitt agar for
18 hours before colony enumeration. Graphs are representative of
two independent experiments performed in duplicate.
Whole Blood Assay
Group A Streptococcus (GAS) was grown to mid-log phase in
Todd-Hewitt Broth (THB, Sigma). A final concentration of
105 CFU/ml was incubated with heparanized human whole
blood containing synthetic d-toxin at 0, 1, 2, or 4 mM. GAS was
plated and colonies enumerated at 0.5, 1, 1.5, and 2 hours post
inoculation. Graph is representative of two independent experi-
ments performed in triplicate.
Spectroscopic Measurements
Synthetic d-toxin (QCB) at 5 mM, was incubated with 5 mM
hBD2 (Peptide International), hBD3 (Peptide International),
CRAMP, LL-37, or 16 mg/ml genomic neutrophil DNA in
20 mM potassium phosphate buffer, pH 7.3. Fluorescence mea-
surements were taken on a Jobin Yvon SPEX FL3-11 spectroflu-
orometer equipped with an R928 photomultiplier tube. Conditions
for tryptophan fluorescence were as follows: excitation wavelength
of 290 nm, emission excitation and emission bandpass of 8 nm and
4 nm, respectively, 1 nm steps, and an integration time of 1s.
Spectroscopic curves of host peptide hBD2, hBD3, CRAMP, or LL-
37 were subtracted from respective d-toxin + host peptide curves.
Similarly, the spectroscopic curve of DNA was subtracted from the
d-toxin + DNA curve.
Immunoblot and Precipitation of Antimicrobial Peptides
Staphylococcus epidermidis ATCC 12228 was grown for 18 hours to
stationary phase in Todd-Hewitt Broth (THB, Sigma). Cells were
centrifuged for 5 mins at 50006g. Supernatants were harvested
and filtered through 0.22 mm PES Express Millex GP filter. 1 mM
final concentration of synthetic CRAMP or LL-37 was added to
1ml of the filtered supernatant and incubated on nutator at room
temperature for 7 hours. Supernatants containing peptides were
precleared with 1 mg control IgG antibody and 20 mL Protein A/
G-Plus agarose (Santa Cruz Biotechnology) for 1.5 hours at 4uC
rotating. Beads were pelleted by centrifugation at 2,5006g for
5 minutes and supernatant was removed and placed in new tube.
The 1 ml precleared supernatant was divided into 2 tubes with
500 mL each. To one tube, 1 mg mouse anti-d-toxin (Abcam) was
added. To the other tube 1 mg IgG control was added. Tubes were
incubated overnight at 4uC, rotating. 20 mL Protein A/G-Plus
agarose were added for 4 hours at 4uC, rotating. Beads were
pelleted by centrifugation at 2,5006g for 5 minutes and washed
three time in ice cold 1x PBS, spinning down after each wash as
described. After the last wash, the supernatant was removed, and
beads were resuspended in sample buffer for direct immunoblot.
Beads were boiled for 5 minutes and loaded into 16% SDS-PAGE
gel along with synthetic peptide as positive control and
biotinylated protein ladder (Amersham) and run at 100V for
1.5 hours. Proteins were transferred to polyvinylidene difluoride
membrane (Bio-Rad) for 2 hours at 4uC. The membrane was
blocked for 1 hour in blocking buffer (PBS, 5% nonfat milk with
3% bovine serum albumin) at room temperature. Incubation in
primary antibody rabbit anti-LL-37 at 1:1000 or rabbit anti-
CRAMP at 1:5000 was performed in blocking buffer overnight
at 4uC. Membranes were then incubated in the appropriate
horseradish peroxidase-conjugated secondary antibody goat anti-
rabbit IgG for 1 hour at 1:5,000 for 1 hour at room temperature,
followed by enhanced chemiluminescence (ECL) detection with
the ECL detection kit (Amersham Biosciences).
Cell Culture and NETs Killing Assay
Neutrophils were purified from healthy donors using the
PolymorphPrep TM system (Axis-Shield, Fresnius). 46104 cells
were added to chamber slides in 500 uL RPMI (Biowhitaker).
26105 cells were added to 96 well plates in RPMI and 5% heat
inactivated plasma. NET killing assays were performed as
previously described [26], with the exception of adding 6 uM d-
toxin to NETs after 4 hours of PMA stimulation. d-toxin was
allowed to bind to NETs for 1 additional hour, so that the total
PMA stimulation time was 5 hours. Media was replaced from
NETs, GAS NZ131 was added, spun down for 10 minutes at
800 g and incubated for 30 minutes. GAS was recovered and
plated for CFU enumeration.
Fluorescence Immunohistochemistry of NETs
Freshly isolated neutrophils in chamber slides were incubated
with 25 nM PMA in DMEM for 4 hours at standard tissue cul-
ture conditions to induce neutrophil extracellular trap formation.
Media was carefully removed and replaced with media con-
taining 5 mM d-toxin for 1 hour. NHEKs, grown on chamber
slides, were incubated with 1 mM d-toxin for 1 hour. Neutrophils
and NHEKs were fixed with 4% PFA for 20 minutes at room
temperature, washed three time with 16 phosphate-buffered
saline (PBS), blocked for 1 hour at room temperature with 3%
bovine serum albumin in 1x PBS, and stained with primary
antibodies mouse anti-d-toxin (Abcam), rabbit anti-LL-37, rabbit
anti-CRAMP (Quality controlled biochemicals, QCB), rabbit
anti-hBD2, and goat anti-hBD3 in 3% bovine serum albumin in
1x PBS overnight at 4uC. After washing the cells 3 times with
PBS, the cells were stained with secondary antibodies goat anti-
mouse IgG (Sigma), anti-rabbit IgG, and anti-goat IgG in 3%
bovine serum albumin in 1x PBS for 1 hour at room
temperature. Slides were mounted in ProLong Anti-Fade reagent
(Molecular Probes).
In Vivo Mouse Experiment
The dorsal skin of wild-type C57BL/6 mice, 8–10 weeks old,
was removed by shaving and Nair (a depilating agent). 4 mm full
thickness punch biopsies were performed on the hair-free dorsal
skin. 5 mL PBS or 5 mL 16 mM d-toxin was added to wounds for
30 minutes. 5 mL of 26106 CFU/ml was added to treated wounds
for an additional 30 minutes. Wounds were harvested using a
6 mm punch biopsy 18 hours post-infection. Wounds were placed
in 1 mL PBS with 1 mm zirconia beads. Samples were bead-
beated for 1 minute, placed on ice, and bead-beated for an
additional minute. Supernatant was serial diluted and plated for
CFU on Todd-Hewitt Agar (THA) as well as assayed for Mip-2
levels using ELISA kit following manufacturer’s instructions (R&D
Systems).
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